Chandler D. Robinson

CEO

Board Member

Equibles does not estimate personal net worth.

Get an email with a short summary when Monopar Therapeutics publishes a filing, an earnings call transcript or a press release.

Get MNPR alerts

About Chandler D. Robinson

Chandler D. Robinson is recorded as Board Member at Monopar Therapeutics (MNPR) since January 1, 2014 and CEO at Monopar Therapeutics (MNPR). The newest filing on record that lists Chandler D. Robinson as CEO and Board Member at Monopar Therapeutics (MNPR) is dated April 30, 2026. The proxy statement of Monopar Therapeutics reports total compensation of $10,637,821 for Chandler D. Robinson in fiscal 2025, including a base salary of $700,000. Disclosed compensation is on record for 6 fiscal years. Monopar Therapeutics is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Monopar Therapeutics includes Karthik Radhakrishnan (CFO and Chief Accounting Officer), Quan A. Vu (CFO), Quan Vu (CFO and Chief Accounting Officer) and 7 others.

Affiliation history

Monopar Therapeutics (MNPR)
Board Member

Proxy statement

Current
2014-01-01–present

Last confirmed April 30, 2026
Monopar Therapeutics (MNPR)
CEO

Proxy statement

Current
Start not stated–present

Last confirmed April 30, 2026

Company network

Monopar Therapeutics

MNPR

Current role

Biotechnology · Healthcare

CEO, Board Member

2014-01-01–present

Leadership on record at Monopar Therapeutics

Karthik Radhakrishnan CFO, Chief Accounting Officer
Quan A. Vu CFO
Quan Vu CFO, Chief Accounting Officer
Andrew Cittadine COO
Andrew J. Cittadine COO
Andrew P. Mazar, Ph.D. Board Member
Arthur J. Klausner, MBA Board Member
Chandler D. Robinson, MD MBA MSc Board Member
Christopher M. Starr Board Member
Christopher M. Starr, Ph.D. Board Member

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2025	Monopar Therapeutics (MNPR)	Chief Executive Officer and Director	$700,000	$550,000	$6,263,958	$2,703,862	$420,000	—	$10,637,821
2024	Monopar Therapeutics (MNPR)	Chief Executive Officer and Director	$603,200	$300,000	—	—	$241,280	—	$1,144,480
2023	Monopar Therapeutics (MNPR)	Chief Executive Officer and Director	$580,000	—	$534,087	$534,080	$130,500	—	$1,778,667
2022	Monopar Therapeutics (MNPR)	Chief Executive Officer and Director	$550,000	—	$446,662	$446,662	$158,125	—	$1,601,448
2020	Monopar Therapeutics (MNPR)	MD, Chief Executive Officer and Director	$504,488	—	$347,752	$637,924	$98,400	—	$1,588,564
2019	Monopar Therapeutics (MNPR)	MD, Chief Executive Officer and Director	$386,250	$62,494	—	—	$37,506	$55,000	$541,250

Recent activity

No call appearances or filed executive changes recorded yet.